Functional, structural, and immunological compartmentalisation of malaria invasive proteins

Biochemical and Biophysical Research Communications

Volumn 354, Issue 2, 2007, Pages 363-371

  Reyes, Claudia ^a   Patarroyo, Manuel Elkin ^a,b   Vargas, Luis Eduardo ^a   Rodríguez, Luis Eduardo ^a   Patarroyo, Manuel Alfonso ^a  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Compartmentalisation; Invasive proteins; Malaria; Structure

Indexed keywords

EPITOPE; GLYCOSYLPHOSPHATIDYLINOSITOL; HLA DR ANTIGEN; MALARIA VACCINE;

ARTICLE; BINDING AFFINITY; CELL MATURATION; CONTROLLED STUDY; HUMAN; IMMUNOREACTIVITY; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; ERYTHROCYTES; HLA-DR ANTIGENS; HUMANS; MALARIA; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 33846489051     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.220     Document Type: Article

References (46)

1. Snow R.W., Guerra C.A., Noor A.M., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
2. Gardner M.J., Hall N., Fung E., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419 (2002) 498-511
3. Bozdech Z., Llinas M., Pulliam B.L., et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 1 (2003) E5
4. Baum J., Maier A.G., Good R.T., et al. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog. 1 (2005) 299-309
5. Patarroyo M.E., Amador R., Clavijo P., et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332 (1988) 158-161
6. Valero M.V., Amador L.R., Galindo C., et al. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341 (1993) 705-710
7. Urquiza M., Rodríguez L.E., Suárez J.E., et al. Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol. 18 (1996) 515-526
8. Rodríguez L.E., Urquiza M., Ocampo M., et al. Plasmodium falciparum EBA-175 kDa protein peptides which bind the human red blood cells. Parasitology 120 (2000) 225-235
9. Patarroyo M.E., Cifuentes G., Vargas L.E., et al. Structure modifications enable conserved peptides to fit into MHC molecules thus inducing protection against malaria. Chembiochem 5 (2004) 1588-1593
10. Marsh S.G.E., Parham P., and Barber L.D. The HLA Facts Book (2000), Academic Press, San Diego
11. Andersson G., Andersson L., Larhammar D., et al. Simplifying genetic locus assignment of HLA-DRB genes. Immunol. Today 15 (1994) 58-62
12. Houghten R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82 (1985) 5131-5135
13. Sinigaglia F., Romagnoli P., Guttinger M., et al. Selection of T cell epitopes and vaccine engineering. Methods Enzymol. 203 (1991) 370-386
14. Greenfield N.J. Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. Anal. Biochem. 235 (1996) 1-10
15. Andersen C.A., Palmer A.G., Brunak S., et al. Continuum secondary structure captures protein flexibility. Structure 10 (2002) 175-184
16. Ocampo M., Urquiza M., Guzmán F., et al. Two MSA2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J. Peptide Res. 55 (2000) 216-223
17. Puentes A., García J., Ocampo M., et al. P. falciparum: merozoite surface protein-8 peptides bind specifically to human erythrocytes. Peptides 24 (2003) 1015-1023
18. Puentes A., Ocampo M., Rodríguez L.E., et al. Identifying Plasmodium falciparum merozoite surface protein-10 human erythrocyte specific binding regions. Biochimie 87 (2005) 461-472
19. Chitarra V., Holm I., Bentley G.A., et al. The crystal structure of C-terminal merozoite surface protein 1 at 1.8 Å resolution, a highly protective malaria vaccine candidate. Mol. Cell 3 (1999) 457-464
20. Urquiza M., Suarez J.E., Cardenas C., et al. Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein. Vaccine 19 (2001) 508-513
21. Feng Z.P., Keizer D.W., Stevenson R.A., et al. Structure and inter-domain interactions of domain II from the blood stage malarial protein, apical membrane antigen 1. J. Mo1. Biol. 350 (2005) 641-656
22. Marti M., Good R.T., Rug M., et al. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 306 (2004) 1930-1933
23. Suárez J.E., Urquiza M., Curtidor H., et al. A GBP 130 Derived Peptide from Plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro. Mem. Inst. Oswaldo Cruz 95 (2000) 495-501
24. Bravo R.V., Marín V., García J., et al. Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes. Vaccine 18 (2000) 1289-1293
25. López R., Urquiza M., Curtidor H., et al. Plasmodium falciparum: red blood cell binding studies of peptides derived from histidine-rich KAHRP-I, HRP-II and HRP-III proteins. Acta Trop. 75 (2000) 349-359
26. Feng Z., Zhang X., Han P., et al. Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. Mol. Biochem. Parasitol. 150 (2006) 256-267
27. Dyson H.J., and Wright P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6 (2005) 197-208
28. Rodríguez L.E., Curtidor H., Ocampo M., et al. Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion. Protein Sci. 14 (2005) 1778-1786
29. Lopez R., Valbuena J., Rodri{dotless}guez L.E., et al. Plasmodium falciparum merozoite surface protein 6 (MSP-6) derived peptides bind erythrocytes and partially inhibit parasite invasion. Peptides 27 (2006) 1685-1692
30. Curtidor H., Urquiza M., Suárez J.E., et al. Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine 19 (2001) 4496-4504
31. Li X., Chen H., Oo T.H., et al. A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J. Biol. Chem. 279 (2004) 5765-5771
32. Kauth C.W., Woehlbier U., Kern M., et al. Interactions between merozoite surface proteins 1, 6 and 7 of the malaria parasite Plasmodium falciparum. J. Biol. Chem. 281 (2006) 31517-31527
33. Blackman M.J., Heidrich H.G., Donachie S., et al. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172 (1990) 379-382
34. Ocampo M., Curtidor H., Vera R., et al. MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochem. Biophys. Res. Commun. 315 (2004) 319-329
35. Ocampo M., Rodríguez L.E., Curtidor H., et al. Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Sci. 14 (2005) 504-513
36. Puentes A., García J., Vera R., et al. Serine repeat antigen peptides which bind specifically to red blood cells. Parasitol. Int. 49 (2000) 105-117
37. Tolia N.H., Enemark E.J., Sim B.K., et al. Structural basis for the EBA 175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122 (2005) 183-193
38. Cifuentes G., Guzman F., Alba M.P., et al. Analysis of a Plasmodium falciparum EBA-175 peptide with high binding capacity to erythrocytes and their analogues using 1H-NMR. J. Struct. Biol. 141 (2003) 115-121
39. Vera Bravo R., Valbuena J.J., Ocampo M., García J.E., et al. Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochimie 87 (2005) 425-436
40. Rodríguez L.E., Ocampo M., Vera R., et al. Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells. J. Peptide Res. 62 (2003) 175-184
41. Curtidor H., Rodríguez L.E., Ocampo M., et al. Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum erythrocyte binding ligand 1 (EBL-1) derived peptides. Protein Science 14 (2005) 464-473
42. Dowse T.J., and Soldati D. Rhomboid-like proteins in apicoplexa: phylogeny and nomenclature. Trends Parasitol. 21 (2005) 254-258
43. Curtidor H., Ocampo M., Tovar D., et al. Specific erythrocyte binding capacity and biological activity of Plasmodium falciparum-derived rhoptry-associated protein 1 peptides. Vaccine 22 (2004) 1054-1062
44. López R., Valbuena J., Curtidor H., et al. Plasmodium falciparum: red blood cell binding studies using peptides derived from rhoptry-associated protein 2 (RAP2). Biochemie 86 (2004) 1-6
45. Valbuena J.J., Vera R., García J., et al. Plasmodium falciparum normocyte binding protein (PfNBP-1) peptides bind specifically to human erythrocytes. Peptides 24 (2003) 1007-1014
46. Ocampo M., Vera R., Rodríguez L.E., et al. Identification of Plasmodium falciparum reticulocyte binding protein RBP-2 homologue a and b (PfRBP-2-Ha and-Hb) sequences that specifically bind to erythrocytes. Parasitol. Int. 53 (2004) 77-88